Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit

Objective Thromboembolic events such as acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary artery embolism and renal artery embolism are a rare condition but a major cause of morbidity and mortality. In this study we discussed low-dose thrombolytic therapy, in patients with thromboembolic events in the intensive care unit.
Methods The study was performed on 12 consecutive patients [8 female; 50.3±16.0 (35–95) years] with acute thromboembolism including acute coronary syndrome related prosthetic heart valve thrombosis, acute pulmonary embolism and acute renal embolism who were treated with low-dose (25 mg) and slow infusion (6 hours) of t-PA. We evaluated mainly in-hospital safety and also effectiveness.Total treatment episodes was 1.66±0.88 (1-4) times.
Results All thromboembolic events have been successfully treated with low-dose (25 mg) and slow infusion (6 hours) of t-PA. The success criteria were clinically improvement and radiologically lysis. None of the patients had ischemic stroke, intracranial hemorrhage, embolism (peripheral and recurrence of coronary artery embolism), bleeding requiring transfusion. The most frequent in-hospital complication was a gum bleeding without need for transfusion (two patients).
Conclusions In our case series low-dose (25 mg) and slow infusion (6 hours) of t-PA have been performed successfully for thromboembolic events including acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary embolism and renal embolism in patients with in the intensive care unit. Safety is promising and if efficacy will be proved; this method may be a valuable alternative to standard fibrinolytic regimen.

1. Rutsch W, Schmutzler H. t-PA in thrombolytic therapy of acute myocardial infarct. Herz. 1994;19(6):336–52. PMID: 7843690

2. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal. 2014;35(43):3033–80. DOI: 10.1093/eurheartj/ehu283

3. Koivuviita N, Tertti R, Heiro M, Manner I, Metsärinne K. Thromboembolism as a Cause of Renal Artery Occlusion and Acute Kidney Injury: The Recovery of Kidney Function after Two Weeks. Case Reports in Nephrology and Dialysis. 2014;4(1):82–7. DOI: 10.1159/000362538

4. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E et al. Comparison of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis. JACC: Cardiovascular Imaging. 2013;6(2):206–16. DOI: 10.1016/j.jcmg.2012.10.016

5. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M et al. Thrombolytic Therapy for the Treatment of Prosthetic Heart Valve Thrombosis in Pregnancy With Low-Dose, Slow Infusion of TissueType Plasminogen Activator. Circulation. 2013;128(5):532–40. DOI: 10.1161/CIRCULATIONAHA.113.001145

6. Gündüz S, Özkan M, Yesin M, Kalçık M, Gürsoy MO, Karakoyun S et al. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 2017;23(3):241–7. DOI: 10.1177/1076029615609698

7. Yesin M, Kalcik M, Gursoy MO, Yıldız M, Özkan M. Delineation of a giant thrombus on a prosthetic mitral valve successfully thrombolysed with low dose slow infusion of tissue plasminogen activator. Koşuyolu Heart Journal. 2015;18(2):109–10. [Av. at: http://www.kosuyoluheartjournal.com/managete/fu_folder/2015-2/2015-18-2-109-110.pdf]. DOI: 10.5578/khj.7158

8. Özkan M, Biteker M, Ekşi Duran N, Yıldız M. Huge Prosthetic Mitral Valve Thrombosis in a Pregnant Woman. Circulation. 2009;120(18):e151-2. DOI: 10.1161/CIRCULATIONAHA.109.873786

9. Aykan AC, Ozkan M, Duran NE, Yildiz M. Acute ST-elevation inferior myocardial infarction in a patient with a non-obstructive mechanical mitral valve thrombosis : case report - online article. Cardiovascular Journal Of Africa. 2012;23(9):e7–8. DOI: 10.5830/CVJA-2012-047

10. Iakobishvili Z, Eisen A, Porter A, Cohen N, Abramson E, Mager A et al. Acute coronary syndromes in patients with prosthetic heart valves—a case-series. Acute Cardiac Care. 2008;10(3):148–51. DOI: 10.1080/17482940701882233

11. Karakoyun S, Gursoy MO, Kalcik M, Yesin M, Özkan M. A case series of prosthetic heart valve thrombosis-derived coronary embolism. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2014;42(5):467–71. DOI: 10.5543/tkda.2014.05031

12. Tang L, Hu X, Zhou S. Coronary Artery Embolism Causing Acute Myocardial Infarction in Patients with Mechanical Heart Valve Prosthesis: Which is the Optimal Treatment? Heart, Lung and Circulation. 2014;23(5):422–7. DOI: 10.1016/j.hlc.2013.10.086

13. Goldhaber SZ, Elliott CG. Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis. Circulation. 2003;108(22):2726–9. DOI: 10.1161/01.CIR.0000097829.89204.0C

14. Yildiz M, Karakoyun S, Acar RD, Ozkan M. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus: Blood Coagulation & Fibrinolysis. 2013;24(1):95–6. DOI: 10.1097/MBC.0b013e328359759c

15. Cagri Aykan A, Boyaci F, Hatem E. Successful treatment of a pulmonary embolism with low dose prolonged infusion of tissue typed plasminogen activator in a 37 year old female in early postoperative period. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 2014;14(4):400–2. DOI: 10.5152/akd.2014.5273

16. Zankl AR, Dengler TJ, Andrassy M, Volz HC, Katus HA, Zeier M. Recovery of renal function after delayed percutaneous dilation of a subtotal in-stent restenosis of the renal artery in a left solitary kidney. Clinical Kidney Journal. 2009;2(3):236–8. DOI: 10.1093/ndtplus/sfp012

17. Abrams HL, Cornell SH. Patterns of collateral flow in renal ischemia. Radiology. 1965;84:1001–12. DOI: 10.1148/84.6.1001

18. Aykan AÇ, Gürsoy OM, Özkan M, Yldz M, Kahveci G, Uslu Z. Successful treatment of renal artery thromboembolism with low-dose prolonged infusion of tissue-typed plasminogen activator in a patient with mitral mechanical heart valve thrombosis under the guidance of multimodality imaging: Blood Coagulation & Fibrinolysis. 2012;23(7):663–5. DOI: 10.1097/MBC.0b013e328355e86d